FDA Approves Cuvposa for Chronic Drooling in Children

Links shared publicly online about this topic.

  • 976
    total visits

FDA Approves Cuvposa for Chronic Drooling in Children

drugs.com

Cuvposa (glycopyrrolate) is used to treat chronic severe drooling. Includes Cuvposa side effects, interactions and indications.

View full resource at drugs.com

Tags: Children's Health, FDA

  • Share

Most Recently Shared on August 2, 2010 at 10:14 pm By:

drugscom Drugs.com

FDA Approves Cuvposa for Chronic Drooling in Children - http://bit.ly/d837HK

2 years ago...

Shionogi launches CUVPOSA for pediatric chronic severe drooling

news-medical.net — “Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. commercial availability of CUVPOSA™ (glycopyrrolate) oral solution, the first and only FDA-approved treatment to reduce chronic severe drooling in patients aged 3 to 16 with neurologic conditions associated with problem drooling, such as cerebral palsy.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on April 7, 2011 at 2:09 pm By:

NewsMedical News-Medical.Net Health News

Shionogi launches CUVPOSA for pediatric chronic severe drooling: Shionogi Inc., the U.S.-based group company of ... http://bit.ly/gMBd6q

1 year ago...

US FDA approves Cuvposa oral solution for chronic drooling in kids - International

pharmabiz.com — “The US Food and Drug Administration approved Cuvposa (glycopyrrolate) oral solution to treat chronic severe drooling caused by neurologic disorders in children ages three years to 16 years.View full resource at pharmabiz.com

  • View Related
  • Share

Most Recently Shared on July 30, 2010 at 11:39 am By:

OralHealth_OW Oral Health OW OW Health

US FDA approves Cuvposa oral solution for chronic drooling in kids: The US Food and Drug Administration approved C... http://bit.ly/bXhGLf

2 years ago...

Shionogi Inc. Announces FDA Approval Of CUVPOSA™ For The Treatment Of Chronic Severe Drooling In Pediatric Patients With Neurologic Conditions

medicalnewstoday.com — “Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd., announced the U.S. Food and Drug Administration approval of CUVPOSA™ (glycopyrrolate), the first liquid treatment for patieView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on July 30, 2010 at 11:39 am By:

Neurology_OW Neurology OW OW Health

Shionogi Inc. Announces FDA Approval Of CUVPOSA For The Treatment Of Chronic Severe Drooling In Pediatric Patients... http://mnt.to/f/3GLX

2 years ago...

Medical News: FDA Approves Drug to Control Kids' Chronic Drooling - in Pediatrics, General Pediatrics from MedPage Today

medpagetoday.com — “A new formulation of glycopyrrolate (Cuvposa) has received FDA approval to treat chronic severe drooling in children ages 3 to 16, the agency said.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on July 30, 2010 at 6:00 am By:

Cuvposa approved for chronic severe drooling associated with neurologic conditions - MPR

empr.com — “The FDA has approved Cuvposa (glycopyrrolate liquid, from Shionogi), an orphan drug, for the treatment of chronic severe drooling associated with neurologic conditions (eg, cerebral palsy) in patients 3"16 years of age.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on July 29, 2010 at 4:02 pm By:

eMPR MPR Medical Publisher

MPR News: Cuvposa approved for chronic severe drooling associated with neurologic conditions: The FDA has approved... http://bit.ly/ar1eRe

2 years ago...

Cuvposa approved for chronic severe drooling associated with neurologic conditions - ONA

oncologynurseadvisor.com — “The FDA has approved Cuvposa (glycopyrrolate liquid, from Shionogi), an orphan drug, for the treatment of chronic severe drooling associated with neurologic conditions (eg, cerebral palsy) in patients 3--16 years of age.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on July 29, 2010 at 3:22 pm By:

ONAcom OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education

Cuvposa approved for chronic severe drooling associated with neurologic conditions http://goo.gl/fb/M8Co8

2 years ago...

FDA Approves Drug For Chronic Drooling In Children

medicalnewstoday.com — “The U.S. Food and Drug Administration approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years.View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on July 29, 2010 at 3:07 pm By:

Medical News: FDA Approves Drug to Control Kids' Chronic Drooling - in Pediatrics, General Pediatrics from MedPage Today

medpagetoday.com — “A new formulation of glycopyrrolate (Cuvposa) has received FDA approval to treat chronic severe drooling in children ages 3 to 16, the agency said.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on July 29, 2010 at 3:07 pm By:

medical_tweets medical_tweets Health News

FDA Approves Drug to Control Kids' Chronic Drooling (MedPage Today) -- A new formulation of glycopyrrolate (Cuvposa) ha.. http://dld.bz/pnvt

2 years ago...

FDA approves Cuvposa Oral Solution for chronic severe drooling in children

news-medical.net — “The U.S. Food and Drug Administration today approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on July 29, 2010 at 6:01 am By:

NewsMedical News-Medical.Net Health News

FDA approves Cuvposa Oral Solution for chronic severe drooling in children: The U.S. Food and Drug Administration ... http://bit.ly/cogyuk

2 years ago...

Advertisement